Northern Trust’s BIO-key International BKYI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-60
Closed -$5.79K 4481
2023
Q3
$5.79K Hold
60
﹤0.01% 4426
2023
Q2
$8.06K Hold
60
﹤0.01% 4490
2023
Q1
$7.51K Hold
60
﹤0.01% 4546
2022
Q4
$6.28K Hold
60
﹤0.01% 4618
2022
Q3
$16K Hold
60
﹤0.01% 4580
2022
Q2
$19K Sell
60
-13
-18% -$4.61K ﹤0.01% 4632
2022
Q1
$32K Hold
73
﹤0.01% 4608
2021
Q4
$29K Hold
73
﹤0.01% 4675
2021
Q3
$47K Hold
73
﹤0.01% 4544
2021
Q2
$50K Hold
73
﹤0.01% 4497
2021
Q1
$46K Buy
+73
New +$52.7K ﹤0.01% 4390
2020
Q4
Sell
-43
Closed -$27K 4377
2020
Q3
$27K Buy
+43
New +$40.6K ﹤0.01% 4175

Other funds holding BKYI

Northern Trust's BKYI Position: Q4 2023 in Review

Northern Trust sold out of BIO-key International (BKYI) in Q4 2023, closing a stake of 60 shares — an estimated $5.79K sold.

Northern Trust first reported a position in BKYI in Q3 2020 and held it in 12 quarters. The position peaked at $50K in Q2 2021. 6 funds tracked by Wall St. Rank hold BKYI as of Q4 2023.

  • Northern Trust reported no remaining BIO-key International position as of Q4 2023 after selling out during the quarter.
  • Northern Trust sold 60 BIO-key International shares in Q4 2023, an estimated $5.79K.
  • Northern Trust first reported a position in BIO-key International in Q3 2020 and held it in 12 quarters.
  • Northern Trust's BIO-key International position peaked at $50K in Q2 2021.
  • 6 funds tracked by Wall St. Rank held BIO-key International as of Q4 2023.

Based on Northern Trust's 13F filing for Q4 2023, filed 13 Feb 2024.